Virtu KCG Holdings’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $264K | Buy |
107,203
+21,008
| +24% | +$51.7K | 0.01% | 1817 |
|
|
2017
Q1 | $198K | Buy |
86,195
+1,592
| +2% | +$3.66K | 0.01% | 2414 |
|
|
2016
Q4 | $83K | Sell |
84,603
-16,355
| -16% | -$16K | ﹤0.01% | 2948 |
|
|
2016
Q3 | $114K | Buy |
+100,958
| New | +$114K | ﹤0.01% | 2583 |
|
|
2016
Q2 | – | Sell |
-10,437
| Closed | -$15K | – | 3061 |
|
|
2016
Q1 | $15K | Sell |
10,437
-26,927
| -72% | -$38.7K | ﹤0.01% | 2615 |
|
|
2015
Q4 | $61K | Buy |
37,364
+22,614
| +153% | +$36.9K | ﹤0.01% | 2585 |
|
|
2015
Q3 | $35K | Sell |
14,750
-52,383
| -78% | -$124K | ﹤0.01% | 2585 |
|
|
2015
Q2 | $183K | Buy |
+67,133
| New | +$183K | ﹤0.01% | 2160 |
|
|
2015
Q1 | – | Sell |
-39,823
| Closed | -$138K | – | 2786 |
|
|
2014
Q4 | $138K | Buy |
+39,823
| New | +$138K | ﹤0.01% | 2202 |
|